CD 123 is a membrane biomarker and a therapeutic target in hematologic malignanciesUgo Testa(Istituto Superiore di Sanità), Arthur E. Frankel(Scott & White Memorial Hospital)Biomarker ResearchFebruary 10, 201410.1186/2050-7771-2-4Cited by 249SaveCiteExport RISWatch citationsRelated PapersBRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin|Molecular Cancer Therapeutics|2005|73